Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KML | $18m x 49m shares is 36c per share | 10/10/09 | 45 | 5.2K | |||
|
|||||||
KML | doh | 16/09/09 | 0 | 672 | |||
|
|||||||
KML | back soonish | 15/09/09 | 0 | 502 | |||
|
|||||||
KML | back soon | 13/09/09 | 0 | 538 | |||
|
|||||||
KML | Ann: Suspension from Official Quotation | 28/08/09 | 9 | 2.3K | |||
|
|||||||
KML | change of code to krl | 26/08/09 | 0 | 589 | |||
|
|||||||
KML | tin deposits in nth queensland | 23/08/09 | 0 | 1.1K | |||
|
|||||||
KML | Ann: Results of Meeting | 21/08/09 | 0 | 649 | |||
|
See All Discussions